2024-09-24 - Analysis Report
## Gilead Sciences Inc (GILD) Stock Analysis Report

**Company Overview:** Gilead Sciences Inc is a biopharmaceutical company that develops and markets treatments for HIV/AIDS, hepatitis B and C, oncology, and inflammatory diseases.

**Performance Analysis:**

**1. Return Rate Comparison:**

Gilead Sciences Inc (GILD) has a cumulative return rate of -12.84% compared to the S&P 500 (VOO) with a return rate of 133.1%. The relative divergence is -145.94, indicating that GILD has significantly underperformed the S&P 500.

**2. Recent Price Volatility:**

* Closing Price: $83.99
* 5-Day Moving Average: $83.86
* 20-Day Moving Average: $80.86
* 60-Day Moving Average: $75.6

This shows a slight upward trend in the stock price over the past 5 days.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 74.46 - Suggests the stock is currently in overbought territory, potentially indicating a near-term correction.
* **PPO (Percentage Price Oscillator):** 0.17 - A positive value indicates a bullish trend, suggesting potential upward momentum.
* **Delta_Previous_Relative_Divergence:** 1.82 - A positive value indicates a short-term upward trend.
* **Expected Return:** 18.43% - This is the projected maximum return on investment over a 5-year period, based on current market conditions.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 1.29 | $6.95 B |
| 2024-05-08 | -3.34 | $6.69 B |
| 2023-11-07 | 1.75 | $7.05 B |
| 2023-08-04 | 0.84 | $6.60 B |
| 2024-08-08 | 0.84 | $6.60 B |

The most recent earnings report for 2024-08-08 shows an EPS of $1.29, exceeding analyst expectations. The revenue of $6.95B also exceeded analyst expectations. This recent performance indicates a positive outlook for Gilead Sciences Inc, potentially justifying the higher than average Expected Return.

**5. Overall Analysis:**

Gilead Sciences Inc (GILD) has underperformed the market significantly, with a negative cumulative return rate compared to the S&P 500. However, recent price action and technical indicators suggest a potential upward trend. The company has also reported positive recent earnings, exceeding analyst expectations. This, coupled with a relatively high expected return, suggests that GILD might be a potential investment opportunity. 

**Disclaimer:** This report is for informational purposes only and should not be considered as investment advice. Always conduct thorough research and consult with a financial advisor before making any investment decisions. 
